Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Vaccines

  Free Subscription


Articles published in J Virol

Retrieve available abstracts of 305 articles:
HTML format



Single Articles


    July 2021
  1. EREZ N, Wyatt LS, Americo JL, Xiao W, et al
    Spontaneous and targeted mutations in the decapping enzyme enhance replication of modified vaccinia virus Ankara (MVA) in monkey cells.
    J Virol. 2021 Jul 7:JVI0110421. doi: 10.1128/JVI.01104.
    PubMed     Abstract available


    June 2021
  2. SKARLUPKA AL, Bebin-Blackwell AG, Sumner SF, Ross TM, et al
    Universal influenza virus neuraminidase vaccine elicits protective immune responses against human seasonal and pre-pandemic strains.
    J Virol. 2021 Jun 23:JVI0075921. doi: 10.1128/JVI.00759.
    PubMed     Abstract available


  3. QIN Y, Tu K, Teng Q, Feng D, et al
    Identification of novel T-cell epitopes on infectious bronchitis virus N protein and development of a multi-epitope vaccine.
    J Virol. 2021 Jun 9:JVI0066721. doi: 10.1128/JVI.00667.
    PubMed     Abstract available


  4. QIN K, Boppana S, Carlson JM, Fiore-Gartland A, et al
    Elevated HIV infection of CD4 T cells in MRKAd5 vaccine recipients due to CD8 T cells targeting of adapted epitopes.
    J Virol. 2021 Jun 2:JVI0016021. doi: 10.1128/JVI.00160.
    PubMed     Abstract available


  5. NELSON SA, Dileepan T, Rasley A, Jenkins MK, et al
    Intranasal nanoparticle vaccination elicits a persistent, polyfunctional CD4 T cell response in the murine lung specific for a highly conserved influenza antigen that are sufficient to mediate protection from influenza virus challenge.
    J Virol. 2021 Jun 2:JVI0084121. doi: 10.1128/JVI.00841.
    PubMed     Abstract available


    May 2021
  6. AO Z, Wang L, Azizi H, Abiola TO, et al
    Development and Evaluation of an Ebola Virus Glycoprotein Mucin-Like Domain Replacement System as a New DC-Targeting Vaccine Approach Against HIV-1.
    J Virol. 2021 May 19. pii: JVI.02368-20. doi: 10.1128/JVI.02368.
    PubMed     Abstract available


  7. CARNELL GW, Ciazynska KA, Wells DA, Xiong X, et al
    SARS-CoV-2 spike protein stabilized in the closed state induces potent neutralizing responses.
    J Virol. 2021 May 7. pii: JVI.00203-21. doi: 10.1128/JVI.00203.
    PubMed     Abstract available


  8. LEE W, Kingstad-Bakke B, Kedl RM, Kawaoka Y, et al
    CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus.
    J Virol. 2021 May 5. pii: JVI.00530-21. doi: 10.1128/JVI.00530.
    PubMed     Abstract available


  9. BORCA MV, Rai A, Ramirez-Medina E, Silva E, et al
    A cell culture-adapted vaccine virus against the current pandemic African swine fever virus strain.
    J Virol. 2021 May 5. pii: JVI.00123-21. doi: 10.1128/JVI.00123.
    PubMed     Abstract available


  10. GOWEN BB, Hickerson BT, York J, Westover JB, et al
    Second-generation live-attenuated Candid#1 vaccine virus resists reversion and protects against lethal Junin virus infection in guinea pigs.
    J Virol. 2021 May 5. pii: JVI.00397-21. doi: 10.1128/JVI.00397.
    PubMed     Abstract available


    April 2021
  11. YE X, Liu X, Shu T, Deng W, et al
    A Live-attenuated Zika Virus Vaccine with High Production Capacity Confers Effective Protection in Neonatal Mice.
    J Virol. 2021 Apr 28. pii: JVI.00383-21. doi: 10.1128/JVI.00383.
    PubMed     Abstract available


  12. VALLEE G, Norris P, Paszkowski P, Noyce R, et al
    Vaccinia virus gene acquisition through non-homologous recombination.
    J Virol. 2021 Apr 28. pii: JVI.00318-21. doi: 10.1128/JVI.00318.
    PubMed     Abstract available


  13. MORI K, Ohniwa RL, Takizawa N, Naito T, et al
    Development of a Genetically Stable Live Attenuated Influenza Vaccine Strain using an Engineered High-Fidelity Viral Polymerase.
    J Virol. 2021 Apr 7. pii: JVI.00493-21. doi: 10.1128/JVI.00493.
    PubMed     Abstract available


  14. HUANG X, Ma Y, Wang Y, Niu C, et al
    Oral probiotics vaccine expressing koi herpesvirus (KHV) ORF81 protein delivered by chitosan-alginate capsules is a promising strategy for mass oral vaccination of carps against KHV infection.
    J Virol. 2021 Apr 7. pii: JVI.00415-21. doi: 10.1128/JVI.00415.
    PubMed     Abstract available


  15. ZHANG H, Zheng H, Guo P, Hu L, et al
    Broadly protective CD8(+) T cell immunity to highly conserved epitopes elicited by heat shock protein gp96-adjuvanted influenza monovalent split vaccine.
    J Virol. 2021 Apr 7. pii: JVI.00507-21. doi: 10.1128/JVI.00507.
    PubMed     Abstract available


  16. PATEL DR, Field CJ, Septer KM, Sim DG, et al
    Transmission and protection against re-infection in the ferret model with the SARS-CoV-2 USA-WA1/2020 reference isolate.
    J Virol. 2021 Apr 7. pii: JVI.02232-20. doi: 10.1128/JVI.02232.
    PubMed     Abstract available


    March 2021
  17. WANG J, Shu T, Deng W, Zheng Y, et al
    Mucosal priming with a recombinant influenza A virus-vectored vaccine elicits T-cell and antibody responses to HIV-1 in mice.
    J Virol. 2021 Mar 31. pii: JVI.00059-21. doi: 10.1128/JVI.00059.
    PubMed     Abstract available


  18. WOLLNER CJ, Richner M, Hassert MA, Pinto AK, et al
    A Dengue Virus Serotype 1 mRNA-LNP Vaccine Elicits Protective Immune Responses.
    J Virol. 2021 Mar 24. pii: JVI.02482-20. doi: 10.1128/JVI.02482.
    PubMed     Abstract available


  19. SCHMID DS, Miao C, Leung J, Johnson M, et al
    Comparative antibody responses to the live-attenuated and recombinant herpes zoster vaccines.
    J Virol. 2021 Mar 24. pii: JVI.00240-21. doi: 10.1128/JVI.00240.
    PubMed     Abstract available


  20. MA J, Su D, Sun Y, Huang X, et al
    Cryo-EM structure of S-Trimer, a subunit vaccine candidate for COVID-19.
    J Virol. 2021 Mar 10. pii: JVI.00194-21. doi: 10.1128/JVI.00194.
    PubMed     Abstract available


  21. JACOB-DOLAN C, Feldman J, McMahan K, Yu J, et al
    Coronavirus-Specific Antibody Cross Reactivity in Rhesus Macaques Following SARS-CoV-2 Vaccination and Infection.
    J Virol. 2021 Mar 10. pii: JVI.00117-21. doi: 10.1128/JVI.00117.
    PubMed     Abstract available


  22. LUO Z, Girton AW, Heaton BE, Heaton NS, et al
    Engineered influenza virions reveal the contributions of non-hemagglutinin structural proteins to vaccine mediated protection.
    J Virol. 2021 Mar 3. pii: JVI.02021-20. doi: 10.1128/JVI.02021.
    PubMed     Abstract available


    February 2021
  23. DHAKAL S, Loube J, Misplon JA, Lo CY, et al
    Effect of an adenovirus-vectored universal influenza virus vaccine on pulmonary pathophysiology in a mouse model.
    J Virol. 2021 Feb 24. pii: JVI.02359-20. doi: 10.1128/JVI.02359.
    PubMed     Abstract available


  24. BINJAWADAGI B, Ma Y, Binjawadagi R, Brakel K, et al
    Mucosal Delivery of Recombinant Vesicular Stomatitis Virus Vectors Expressing Envelope Proteins of Respiratory Syncytial Virus Induces Protective Immunity in Cotton Rats.
    J Virol. 2021;95.
    PubMed     Abstract available


  25. LEVY Y, Lacabaratz C, Lhomme E, Wiedemann A, et al
    A randomized placebo-controlled efficacy study of a prime boost therapeutic vaccination strategy in HIV-1 infected individuals: VRI02 ANRS 149 LIGHT Phase II trial.
    J Virol. 2021 Feb 10. pii: JVI.02165-20. doi: 10.1128/JVI.02165.
    PubMed     Abstract available


    January 2021
  26. TAK AI, Americo JL, Diesterbeck US, Moss B, et al
    Loss of the vaccinia virus 35-amino acid hydrophobic O3 protein is partially compensated by mutations in the transmembrane domains of other entry proteins.
    J Virol. 2021 Jan 27. pii: JVI.02228-20. doi: 10.1128/JVI.02228.
    PubMed     Abstract available


  27. DOMINGO E, Perales C
    The time for COVID-19 vaccination.
    J Virol. 2021 Jan 19. pii: JVI.02437-20. doi: 10.1128/JVI.02437.
    PubMed     Abstract available


  28. SANGARE K, Tuero I, Rahman MA, Hoang T, et al
    The immunological impact of adenovirus early genes on vaccine-induced responses in mice and nonhuman primates.
    J Virol. 2021 Jan 13. pii: JVI.02253-20. doi: 10.1128/JVI.02253.
    PubMed     Abstract available


  29. RICO AB, Linville AC, Olson AT, Wang Z, et al
    The Vaccinia Virus B12 Pseudokinase Represses Viral Replication via Interaction with the Cellular Kinase VRK1 and Activation of the Antiviral Effector BAF.
    J Virol. 2021;95.
    PubMed     Abstract available


  30. SHI Y, Shi J, Sun L, Tan Y, et al
    Insight into vaccine development for Alpha-coronaviruses based on structural and immunological analyses of spike proteins.
    J Virol. 2021 Jan 7. pii: JVI.02284-20. doi: 10.1128/JVI.02284.
    PubMed     Abstract available


  31. GARCIA-ARRIAZA J, Garaigorta U, Perez P, Lazaro-Frias A, et al
    COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike induce robust T- and B-cell immune responses and full efficacy in mice.
    J Virol. 2021 Jan 7. pii: JVI.02260-20. doi: 10.1128/JVI.02260.
    PubMed     Abstract available


  32. JIN WP, Lu J, Zhang XY, Wu J, et al
    Efficacy of Coxsackievirus A5 Vaccine Candidates in an Actively Immunized Mouse Model.
    J Virol. 2021 Jan 6. pii: JVI.01743-20. doi: 10.1128/JVI.01743.
    PubMed     Abstract available


    December 2020
  33. EVERETT HE, van Diemen PM, Aramouni M, Ramsay A, et al
    Vaccines That Reduce Viral Shedding Do Not Prevent Transmission of H1N1 Pandemic 2009 Swine Influenza a Virus Infection to Unvaccinated Pigs.
    J Virol. 2020 Dec 2. pii: JVI.01787-20. doi: 10.1128/JVI.01787.
    PubMed     Abstract available


    November 2020
  34. UNO N, Ross TM
    A Universal Dengue Vaccine Elicits Neutralizing Antibodies Against Strains from All Four Dengue Serotypes.
    J Virol. 2020 Nov 18. pii: JVI.00658-20. doi: 10.1128/JVI.00658.
    PubMed     Abstract available


  35. JENKINS T, Wang R, Harder O, Xue M, et al
    A novel live attenuated RSV vaccine candidate with mutations in the L protein SAM binding site and the G protein cleavage site is protective in cotton rats and a rhesus macaque.
    J Virol. 2020 Nov 11. pii: JVI.01568-20. doi: 10.1128/JVI.01568.
    PubMed     Abstract available


  36. TIAN X, Landreth S, Lu Y, Pandey K, et al
    A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.
    J Virol. 2020 Nov 11. pii: JVI.02154-20. doi: 10.1128/JVI.02154.
    PubMed     Abstract available


    October 2020
  37. GHORBANI A, Abundo MC, Ji H, Taylor KJM, et al
    Viral Subpopulation Screening Guides in Designing a High Interferon Inducing Live Attenuated Influenza Vaccine by Targeting Rare Mutations in NS1 and PB2 Proteins.
    J Virol. 2020 Oct 28. pii: JVI.01722-20. doi: 10.1128/JVI.01722.
    PubMed     Abstract available


  38. RENEER ZB, Jamieson PJ, Skarlupka AL, Huang Y, et al
    Computationally Optimized Broadly Reactive H2 HA Influenza Vaccines Elicited Broadly Cross-Reactive Antibodies and Protected Mice from Viral Challenges.
    J Virol. 2020 Oct 28. pii: JVI.01526-20. doi: 10.1128/JVI.01526.
    PubMed     Abstract available


  39. LIANG B, Matsuoka Y, Le Nouen C, Liu X, et al
    A parainfluenza virus vector expressing the respiratory syncytial virus (RSV) prefusion F protein is more effective than RSV for boosting a primary immunization with RSV.
    J Virol. 2020 Oct 28. pii: JVI.01512-20. doi: 10.1128/JVI.01512.
    PubMed     Abstract available


  40. ELENA GOMEZ C, Perdiguero B, Falqui M, Quiros M, et al
    Enhancement of HIV-1 Env-specific CD8 T cell responses using IFN-Stimulated Gene 15 (ISG15) as an immune adjuvant.
    J Virol. 2020 Oct 28. pii: JVI.01155-20. doi: 10.1128/JVI.01155.
    PubMed     Abstract available


  41. KANAI Y, Onishi M, Kawagishi T, Pannacha P, et al
    Reverse genetics approach for developing rotavirus vaccine candidates carrying VP4 and VP7 genes cloned from clinical isolates of human rotavirus.
    J Virol. 2020 Oct 21. pii: JVI.01374-20. doi: 10.1128/JVI.01374.
    PubMed     Abstract available


  42. KATO S, Shida H, Okamura T, Zhang X, et al
    CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts.
    J Virol. 2020 Oct 21. pii: JVI.01718-20. doi: 10.1128/JVI.01718.
    PubMed     Abstract available


  43. DEVASUNDARAM S, Rosati M, Valentin A, Weiss S, et al
    Priming with DNA expressing trimeric HIV V1V2 alters the immune hierarchy favoring the development of V2-specific antibodies in rhesus macaques.
    J Virol. 2020 Oct 21. pii: JVI.01193-20. doi: 10.1128/JVI.01193.
    PubMed     Abstract available


  44. MARTINS MA, Gonzalez-Nieto L, Ricciardi MJ, Bailey VK, et al
    Rectal Acquisition of SIVmac239 Infection Despite Vaccine-Induced Immune Responses Against the Entire SIV Proteome.
    J Virol. 2020 Oct 7. pii: JVI.00979-20. doi: 10.1128/JVI.00979.
    PubMed     Abstract available


  45. BAGRI P, Ghasemi R, McGrath JJC, Thayaparan D, et al
    Estradiol enhances anti-viral CD4(+) tissue-resident memory T cell responses following mucosal herpes simplex virus 2 vaccination through an IL-17-mediated pathway.
    J Virol. 2020 Oct 7. pii: JVI.01206-20. doi: 10.1128/JVI.01206.
    PubMed     Abstract available


  46. DE LORENZO G, Tandavanitj R, Doig J, Setthapramote C, et al
    Zika virus-like particles bearing covalent dimer of envelope protein protect mice from lethal challenge.
    J Virol. 2020 Oct 7. pii: JVI.01415-20. doi: 10.1128/JVI.01415.
    PubMed     Abstract available


    September 2020
  47. CRIADO MF, Sa E Silva M, Lee DH, de Lima Salge CA, et al
    Cross-protection by inactivated H5 pre-pandemic vaccine seed strains against diverse Goose/Guangdong lineage H5N1 highly pathogenic avian influenza viruses.
    J Virol. 2020 Sep 30. pii: JVI.00720-20. doi: 10.1128/JVI.00720.
    PubMed     Abstract available


  48. VOIC H, de Vries RD, Sidney J, Rubiro P, et al
    Identification and characterization of CD4+ T cell epitopes after Shingrix vaccination.
    J Virol. 2020 Sep 30. pii: JVI.01641-20. doi: 10.1128/JVI.01641.
    PubMed     Abstract available


  49. XUE M, Wang R, Harder O, Chen P, et al
    Stable attenuation of human respiratory syncytial virus for live vaccines by deletion and insertion of amino acids in the hinge region between the mRNA capping and methyltransferase domains of the large polymerase protein.
    J Virol. 2020 Sep 30. pii: JVI.01831-20. doi: 10.1128/JVI.01831.
    PubMed     Abstract available


  50. GMYREK GB, Filiberti A, Montgomery M, Chitrakar A, et al
    HSV-1 0DeltaNLS Live-Attenuated Vaccine Protects Against Ocular HSV-1 Infection in the Absence of Neutralizing Antibody in HSV-1 gB T Cell Receptor-Specific Transgenic Mice.
    J Virol. 2020 Sep 30. pii: JVI.01000-20. doi: 10.1128/JVI.01000.
    PubMed     Abstract available


  51. SCHORCHT A, van den Kerkhof TLGM, Cottrell CA, Allen JD, et al
    Neutralizing antibody responses induced by HIV-1 envelope glycoprotein SOSIP trimers derived from elite neutralizers.
    J Virol. 2020 Sep 30. pii: JVI.01214-20. doi: 10.1128/JVI.01214.
    PubMed     Abstract available


  52. GODI A, Boampong D, Elegunde B, Panwar K, et al
    Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised Against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes.
    J Virol. 2020 Sep 23. pii: JVI.01236-20. doi: 10.1128/JVI.01236.
    PubMed     Abstract available


  53. CHOI JA, Goo J, Yang E, Jung DI, et al
    Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.
    J Virol. 2020 Sep 23. pii: JVI.01176-20. doi: 10.1128/JVI.01176.
    PubMed     Abstract available


  54. MUSICH T, Thovarai V, Venzon DJ, Mohanram V, et al
    A prime/boost vaccine regimen alters the rectal microbiome and impacts immune responses and viremia control post-SIV infection in male and female rhesus macaques.
    J Virol. 2020 Sep 23. pii: JVI.01225-20. doi: 10.1128/JVI.01225.
    PubMed     Abstract available


  55. CHANDRASEKAR SS, Kingstad-Bakke B, Wu CW, Suresh M, et al
    A Novel Mucosal Adjuvant System for Immunization against Avian Coronavirus Causing Infectious Bronchitis.
    J Virol. 2020;94.
    PubMed     Abstract available


  56. YE C, de la Torre JC, Martinez-Sobrido L
    Development of Reverse Genetics for the Prototype New World Mammarenavirus Tacaribe Virus.
    J Virol. 2020;94.
    PubMed     Abstract available


  57. PIERCE BG, Keck ZY, Wang R, Lau P, et al
    Structure-based design of hepatitis C virus E2 glycoprotein improves serum binding and cross-neutralization.
    J Virol. 2020 Sep 2. pii: JVI.00704-20. doi: 10.1128/JVI.00704.
    PubMed     Abstract available


    August 2020
  58. THOMAS A, Thiono DJ, Kudlacek ST, Forsberg J, et al
    Dimerization of Dengue Virus E Subunits Impacts Antibody Function and Domain Focus.
    J Virol. 2020;94.
    PubMed     Abstract available


  59. WANG W, Liu Q, Li T, Geng T, et al
    Fiber-1, Not Fiber-2, Directly Mediates the Infection of the Pathogenic Serotype 4 Fowl Adenovirus via Its Shaft and Knob Domains.
    J Virol. 2020;94.
    PubMed     Abstract available


  60. XIE L, Han Y, Ma Y, Yuan M, et al
    P108 and T109 on E2 Glycoprotein Domain I Are Critical for the Adaptation of Classical Swine Fever Virus to Rabbits but Not for Virulence in Pigs.
    J Virol. 2020;94.
    PubMed     Abstract available


  61. WANG Y, Lv Y, Niu X, Dong J, et al
    L226Q mutation on influenza H7N9 virus hemagglutinin increases receptor-binding avidity and leads to biased antigenicity evaluation.
    J Virol. 2020 Aug 12. pii: JVI.00667-20. doi: 10.1128/JVI.00667.
    PubMed     Abstract available


  62. CROFT S, Wong YC, Smith SA, Flesch IEA, et al
    Surprisingly Effective Priming of CD8(+) T cells by Heat-Inactivated Vaccinia Virus Virions.
    J Virol. 2020 Aug 5. pii: JVI.01486-20. doi: 10.1128/JVI.01486.
    PubMed     Abstract available


    July 2020
  63. MONTICELLI SR, Bryk P, Ward BM
    The Molluscum Contagiosum Gene MC021L Partially Compensates for the Loss of Its Vaccinia Virus Homolog F13L.
    J Virol. 2020 Jul 29. pii: JVI.01496-20. doi: 10.1128/JVI.01496.
    PubMed     Abstract available


  64. RESCH TK, Wang Y, Moon S, Jiang B, et al
    Serial Passaging of the Human Rotavirus CDC-9 Strain in Cell Culture Leads to Attenuation: Characterization from In Vitro and In Vivo Studies.
    J Virol. 2020;94.
    PubMed     Abstract available


  65. SENKEVICH TG, Zhivkoplias EK, Weisberg AS, Moss B, et al
    Inactivation of genes by frameshift mutations provides rapid adaptation of an attenuated vaccinia virus.
    J Virol. 2020 Jul 15. pii: JVI.01053-20. doi: 10.1128/JVI.01053.
    PubMed     Abstract available


  66. AHLEN G, Frelin L, Nekoyan N, Weber F, et al
    The SARS-CoV-2 N protein is a good component in a vaccine.
    J Virol. 2020 Jul 13. pii: JVI.01279-20. doi: 10.1128/JVI.01279.
    PubMed     Abstract available


  67. SANCHEZ-CORDON PJ, Jabbar T, Chapman D, Dixon LK, et al
    Absence of Long-Term Protection in Domestic Pigs Immunized with Attenuated African Swine Fever Virus Isolate OURT88/3 or BeninDeltaMGF Correlates with Increased Levels of Regulatory T Cells and Interleukin-10.
    J Virol. 2020;94.
    PubMed     Abstract available


    June 2020
  68. MOORE JP, Klasse PJ
    SARS-CoV-2 vaccines: 'Warp Speed' needs mind melds not warped minds.
    J Virol. 2020 Jun 26. pii: JVI.01083-20. doi: 10.1128/JVI.01083.
    PubMed     Abstract available


  69. POWELL RL, Weiss S, Fox A, Liu X, et al
    An HIV vaccine targeting the V2 region of Envelope induces a highly durable polyfunctional Fc-mediated antibody response in rhesus macaques.
    J Virol. 2020 Jun 17. pii: JVI.01175-20. doi: 10.1128/JVI.01175.
    PubMed     Abstract available


  70. LI A, Xue M, Attia Z, Yu J, et al
    Vesicular stomatitis virus and DNA vaccines expressing Zika virus nonstructural protein 1 (NS1) induce substantial but not sterilizing protection against Zika virus infection.
    J Virol. 2020 Jun 17. pii: JVI.00048-20. doi: 10.1128/JVI.00048.
    PubMed     Abstract available


  71. DUTTA NK, Mazumdar K, Gordy JT
    The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development.
    J Virol. 2020;94.
    PubMed    


  72. YANG D, Sun C, Gao R, Wang H, et al
    A temperature-dependent translation defect caused by IRES mutation attenuates foot-and-mouth disease virus: Implications for rational vaccine design.
    J Virol. 2020 Jun 3. pii: JVI.00990-20. doi: 10.1128/JVI.00990.
    PubMed     Abstract available


  73. ZHENG A, Sun W, Xiong X, Freyn AW, et al
    Enhancing Neuraminidase Immunogenicity of Influenza A Viruses by Rewiring RNA Packaging Signals.
    J Virol. 2020 Jun 3. pii: JVI.00742-20. doi: 10.1128/JVI.00742.
    PubMed     Abstract available


    May 2020
  74. SCHNEIDER M, Muller M, Yigitliler A, Xi J, et al
    An Orf Virus-based therapeutic vaccine for the treatment of papillomavirus-induced tumors.
    J Virol. 2020 May 13. pii: JVI.00398-20. doi: 10.1128/JVI.00398.
    PubMed     Abstract available


  75. REDDY VRAP, Sadigh Y, Tang N, Yao Y, et al
    Novel Insights into the Roles of Bcl-2 Homolog Nr-13 (vNr-13) Encoded by Herpesvirus of Turkeys in the Virus Replication Cycle, Mitochondrial Networks, and Apoptosis Inhibition.
    J Virol. 2020;94.
    PubMed     Abstract available


    April 2020
  76. EBERHARDT CS, Wieland A, Nasti TH, Grifoni A, et al
    Persistence of varicella zoster virus specific plasma cells in adult human bone marrow following childhood vaccination.
    J Virol. 2020 Apr 22. pii: JVI.02127-19. doi: 10.1128/JVI.02127.
    PubMed     Abstract available


  77. YANG J, Ma C, Zhao Y, Fan A, et al
    Hepatitis B virus core particles containing a conserved region of the G protein combined with interleukin-35 protected mice against respiratory syncytial virus infection without vaccine-enhanced immunopathology.
    J Virol. 2020 Apr 22. pii: JVI.00007-20. doi: 10.1128/JVI.00007.
    PubMed     Abstract available


  78. DU PONT V, Wirblich C, Yoon JJ, Cox RM, et al
    Identification and Characterization of a Small-Molecule Rabies Virus Entry Inhibitor.
    J Virol. 2020 Apr 22. pii: JVI.00321-20. doi: 10.1128/JVI.00321.
    PubMed     Abstract available


  79. SONG Y, Feng N, Sanchez-Tacuba L, Yasukawa LL, et al
    Reverse Genetics Reveals a Role of Rotavirus VP3 Phosphodiesterase Activity in Inhibiting RNase L Signaling and Contributing to Intestinal Viral Replication In Vivo.
    J Virol. 2020;94.
    PubMed     Abstract available


  80. RAMSEY NLM, Visciano M, Hunte R, Loh LN, et al
    A single-cycle glycoprotein D deletion viral vaccine candidate, DeltagD-2, elicits polyfunctional antibodies that protect against ocular herpes simplex virus.
    J Virol. 2020 Apr 15. pii: JVI.00335-20. doi: 10.1128/JVI.00335.
    PubMed     Abstract available


  81. CHUANG GY, Lai YT, Boyington JC, Cheng C, et al
    Development of a 3Mut-Apex-Stabilized Envelope Trimer that Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses.
    J Virol. 2020 Apr 15. pii: JVI.00074-20. doi: 10.1128/JVI.00074.
    PubMed     Abstract available


  82. SHIBUYA M, Aoshi T, Kuroda E, Yoshioka Y, et al
    Murine cross-reactive non-neutralizing polyclonal IgG1 antibodies induced by influenza vaccine inhibit the cross-protective effect of IgG2 against heterologous virus in mice.
    J Virol. 2020 Apr 8. pii: JVI.00323-20. doi: 10.1128/JVI.00323.
    PubMed     Abstract available


    March 2020
  83. BOON SS, Xia C, Lim JY, Chen Z, et al
    Human Papillomavirus 58 E7 T20I/G63S Variant Isolated from an East Asian Population Possesses High Oncogenicity.
    J Virol. 2020;94.
    PubMed     Abstract available


  84. PATEL CD, Taylor SA, Mehrbach J, Awasthi S, et al
    Trivalent glycoprotein subunit vaccine prevents neonatal herpes simplex virus mortality and morbidity.
    J Virol. 2020 Mar 18. pii: JVI.02163-19. doi: 10.1128/JVI.02163.
    PubMed     Abstract available


  85. YANG H, Wang Y, Ye C
    Rapid Generation of Attenuated Infectious Bursal Disease Virus from Dual-Promoter Plasmids by Reduction of Viral Ribonucleoprotein Activity.
    J Virol. 2020;94.
    PubMed     Abstract available


  86. COTTER CA, Moss B
    Mutations Near the N-Terminus of the Vaccinia Virus G9 Protein Overcome Restrictions on Cell Entry and Syncytium Formation Imposed by the A56/K2 Fusion Regulatory Complex.
    J Virol. 2020 Mar 4. pii: JVI.00077-20. doi: 10.1128/JVI.00077.
    PubMed     Abstract available


  87. HONG GC, Tsai CH, Chang W
    Experimental evolution to isolate vaccinia virus adaptive G9 mutants that overcome membrane fusion inhibition by vaccinia A56/K2 protein complex.
    J Virol. 2020 Mar 4. pii: JVI.00093-20. doi: 10.1128/JVI.00093.
    PubMed     Abstract available


  88. GRIFONI A, Voic H, Dhanda SK, Kidd CK, et al
    T cell responses induced by attenuated flavivirus vaccination are specific and show limited cross-reactivity with other flavivirus species.
    J Virol. 2020 Mar 4. pii: JVI.00089-20. doi: 10.1128/JVI.00089.
    PubMed     Abstract available


    February 2020
  89. SINGH K, Marasini B, Chen X, Ding L, et al
    A bivalent, spherical virus-like particle vaccine enhances breadth of immune responses against pathogenic Ebola viruses in rhesus macaques.
    J Virol. 2020 Feb 19. pii: JVI.01884-19. doi: 10.1128/JVI.01884.
    PubMed     Abstract available


  90. DOEPKER LE, Simonich CA, Ralph D, Shipley MM, et al
    Diversity and function of maternal HIV-1-specific antibodies at the time of vertical transmission.
    J Virol. 2020 Feb 19. pii: JVI.01594-19. doi: 10.1128/JVI.01594.
    PubMed     Abstract available


  91. NELSON CS, Jenks JA, Pardi N, Goodwin M, et al
    HCMV glycoprotein B nucleoside-modified mRNA vaccine elicits antibody responses with greater durability and breadth than MF59-adjuvanted gB protein immunization.
    J Virol. 2020 Feb 12. pii: JVI.00186-20. doi: 10.1128/JVI.00186.
    PubMed     Abstract available


  92. ISHII H, Terahara K, Nomura T, Takeda A, et al
    A novel immunogen selectively eliciting CD8(+) T cells but not CD4(+) T cells targeting immunodeficiency virus antigens.
    J Virol. 2020 Feb 5. pii: JVI.01876-19. doi: 10.1128/JVI.01876.
    PubMed     Abstract available


    January 2020
  93. MANNING JT, Yun NE, Seregin AV, Koma T, et al
    The glycoprotein of the live-attenuated Junin virus vaccine strain induces ER stress and forms aggregates prior to degradation in the lysosome.
    J Virol. 2020 Jan 29. pii: JVI.01693-19. doi: 10.1128/JVI.01693.
    PubMed     Abstract available


  94. SKARLUPKA AL, Reneer ZB, Abreu RB, Ross TM, et al
    An influenza HA Computationally Optimized Broadly Reactive Antigen elicits antibodies endowed with group-1 heterosubtypic breadth against swine influenza viruses.
    J Virol. 2020 Jan 29. pii: JVI.02061-19. doi: 10.1128/JVI.02061.
    PubMed     Abstract available


  95. BORCA MV, Ramirez-Medina E, Silva E, Vuono E, et al
    Development of a highly effective African swine fever virus vaccine by deletion of the I177L gene results in sterile immunity against the current epidemic Eurasia strain.
    J Virol. 2020 Jan 22. pii: JVI.02017-19. doi: 10.1128/JVI.02017.
    PubMed     Abstract available


  96. FUERY A, Pursell T, Tan J, Peng R, et al
    Lethal Hemorrhagic Disease and Clinical Illness Associated with Elephant Endotheliotropic Herpesvirus 1 Are Caused by Primary Infection: Implications for the Detection of Diagnostic Proteins.
    J Virol. 2020;94.
    PubMed     Abstract available


  97. MONTICELLI SR, Earley AK, Stone R, Norbury CC, et al
    Vaccinia Virus Glycoproteins A33, A34, and B5 Form a Complex for Efficient Endoplasmic Reticulum to trans-Golgi Network Transport.
    J Virol. 2020 Jan 15. pii: JVI.02155-19. doi: 10.1128/JVI.02155.
    PubMed     Abstract available


  98. WANG S, Voronin Y, Zhao P, Ishihara M, et al
    Glycan profiles of gp120 protein vaccines from four major HIV-1 subtypes produced from different host cell lines under non-GMP or GMP conditions.
    J Virol. 2020 Jan 15. pii: JVI.01968-19. doi: 10.1128/JVI.01968.
    PubMed     Abstract available


  99. MA S, Zhang B, Shi J, Yin X, et al
    Amino Acid Mutations A286V and T437M in the Nucleoprotein Attenuate H7N9 Viruses in Mice.
    J Virol. 2020;94.
    PubMed     Abstract available


  100. XUE Q, Xu H, Liu H, Pan J, et al
    Epitope Containing Short Peptides Capture Distinct IgG Serodynamics that Enable DIVA for Live-attenuated Vaccines.
    J Virol. 2020 Jan 2. pii: JVI.01573-19. doi: 10.1128/JVI.01573.
    PubMed     Abstract available


  101. IMURA A, Sudaka Y, Takashino A, Tamura K, et al
    Development of an enterovirus 71 vaccine efficacy test using human scavenger receptor B2 transgenic mice.
    J Virol. 2020 Jan 2. pii: JVI.01921-19. doi: 10.1128/JVI.01921.
    PubMed     Abstract available


  102. SILVA DE CASTRO I, Gordon SN, Liu J, Bissa M, et al
    Expression of CD40L by the ALVAC-SIV vector abrogates T cell responses in macaques.
    J Virol. 2020 Jan 2. pii: JVI.01933-19. doi: 10.1128/JVI.01933.
    PubMed     Abstract available


    December 2019
  103. HUANG Y, Owino SO, Crevar CJ, Carter DM, et al
    N-Linked Glycans and K147 Residue on Hemagglutinin Synergize to Elicit Broadly-Reactive H1N1 Influenza Antibodies.
    J Virol. 2019 Dec 18. pii: JVI.01432-19. doi: 10.1128/JVI.01432.
    PubMed     Abstract available


  104. VERMA A, Schmidt BA, Elizaldi SR, Nguyen NK, et al
    Impact of Th1 CD4 TFH skewing on Antibody Responses to an HIV-1 Vaccine in Rhesus Macaques.
    J Virol. 2019 Dec 11. pii: JVI.01737-19. doi: 10.1128/JVI.01737.
    PubMed     Abstract available


  105. QIU Y, Stegalkina S, Zhang J, Boudanova E, et al
    Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
    J Virol. 2019 Dec 11. pii: JVI.01035-19. doi: 10.1128/JVI.01035.
    PubMed     Abstract available


  106. VALESANO AL, Fitzsimmons WJ, McCrone JT, Petrie JG, et al
    Influenza B viruses exhibit lower within-host diversity than influenza A viruses in human hosts.
    J Virol. 2019 Dec 4. pii: JVI.01710-19. doi: 10.1128/JVI.01710.
    PubMed     Abstract available


  107. CHIUPPESI F, Nguyen J, Park S, Contreras H, et al
    Correction for Chiuppesi et al., "Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Responses against Human Cytomegalovirus in Mice".
    J Virol. 2019;93.
    PubMed    


    November 2019
  108. SCHNEIDER JR, Shen X, Orlandi C, Nyanhete T, et al
    A MUC16 IgG binding activity selects for a restricted subset of IgG enriched for certain SIV epitope specificities.
    J Virol. 2019 Nov 27. pii: JVI.01246-19. doi: 10.1128/JVI.01246.
    PubMed     Abstract available


  109. EASTERHOFF D, Pollara J, Luo K, Tolbert WD, et al
    Boosting with AIDSVAX B/E enhances Env constant region 1 and 2 antibody-dependent cellular cytotoxicity breadth and potency.
    J Virol. 2019 Nov 27. pii: JVI.01120-19. doi: 10.1128/JVI.01120.
    PubMed     Abstract available


  110. SMITH A, Rodriguez L, Ghouayel ME, Nogales A, et al
    A live-attenuated influenza vaccine (LAIV) elicits enhanced heterologous protection when the internal genes of the vaccine are matched to the challenge virus.
    J Virol. 2019 Nov 20. pii: JVI.01065-19. doi: 10.1128/JVI.01065.
    PubMed     Abstract available


  111. RIJAL P, Wang BB, Tan TK, Schimanski L, et al
    Broadly inhibiting anti-neuraminidase monoclonal antibodies induced by trivalent influenza vaccine and H7N9 infection in humans.
    J Virol. 2019 Nov 20. pii: JVI.01182-19. doi: 10.1128/JVI.01182.
    PubMed     Abstract available


  112. RUSSIER M, Yang G, Briard B, Meliopoulos V, et al
    HA stability regulates H1N1 influenza virus replication and pathogenicity in mice by modulating type I interferon responses in dendritic cells.
    J Virol. 2019 Nov 6. pii: JVI.01423-19. doi: 10.1128/JVI.01423.
    PubMed     Abstract available


    October 2019
  113. BOPPANA S, Fiore-Gartland A, Bansal A, Goepfert P, et al
    Cross-reactive CD8 T-cell responses elicited by Ad5-based HIV-1 vaccines contributed to early viral evolution in vaccine recipients who became infected.
    J Virol. 2019 Oct 23. pii: JVI.01632-19. doi: 10.1128/JVI.01632.
    PubMed     Abstract available


  114. HAHN AS, Bischof GF, Grosskopf AK, Shin YC, et al
    A Recombinant Rhesus Monkey Rhadinovirus Deleted of Glycoprotein L Establishes Persistent Infection of Rhesus Macaques and Elicits Conventional T Cell Responses.
    J Virol. 2019 Oct 23. pii: JVI.01093-19. doi: 10.1128/JVI.01093.
    PubMed     Abstract available


  115. RINGE RP, Colin P, Torres JL, Yasmeen A, et al
    SOS and IP modifications predominantly affect the yield but not other properties of SOSIP.664 HIV-1 Env glycoprotein trimers.
    J Virol. 2019 Oct 16. pii: JVI.01521-19. doi: 10.1128/JVI.01521.
    PubMed     Abstract available


  116. BOUKHVALOVA MS, Mortensen E, Mbaye A, Lopez D, et al
    Herpes Simplex Virus 1 induces brain inflammation and multifocal demyelination in cotton rats Sigmodon hispidus.
    J Virol. 2019 Oct 9. pii: JVI.01161-19. doi: 10.1128/JVI.01161.
    PubMed     Abstract available


    September 2019
  117. YE L, Ohnemus A, Ong LC, Gad HH, et al
    Type I and type III interferons differ in their adjuvant activities for influenza vaccines.
    J Virol. 2019 Sep 11. pii: JVI.01262-19. doi: 10.1128/JVI.01262.
    PubMed     Abstract available


  118. LIU Y, Freed DC, Li L, Tang A, et al
    A Replication Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural Infection.
    J Virol. 2019 Sep 11. pii: JVI.00747-19. doi: 10.1128/JVI.00747.
    PubMed     Abstract available


  119. BLANCO JCG, Fernando LR, Zhang W, Kamali A, et al
    Alternative Virus-Like Particle-Associated Pre-Fusion F Proteins as Maternal Vaccines for Respiratory Syncytial Virus.
    J Virol. 2019 Sep 11. pii: JVI.00914-19. doi: 10.1128/JVI.00914.
    PubMed     Abstract available


  120. CHOI KY, El-Hamdi NS, McGregor A
    Inclusion of the viral pentamer complex in a vaccine design greatly improves protection against congenital cytomegalovirus in the guinea pig model.
    J Virol. 2019 Sep 4. pii: JVI.01442-19. doi: 10.1128/JVI.01442.
    PubMed     Abstract available


  121. BYRD-LEOTIS L, Gao C, Jia N, Mehta A, et al
    Antigenic pressure on H3N2 influenza drift strains imposes constraints on binding to sialylated receptors, but not phosphorylated glycans.
    J Virol. 2019 Sep 4. pii: JVI.01178-19. doi: 10.1128/JVI.01178.
    PubMed     Abstract available


    August 2019
  122. JOHNSON J, Freedman H, Logan M, Wong JAJ, et al
    A recombinant HCV genotype 1a E1/E2 envelope glycoprotein vaccine elicits antibodies that differentially neutralize closely related 2a strains through interactions of the N-terminal hypervariable region 1 of E2 with scavenger receptor B1.
    J Virol. 2019 Aug 28. pii: JVI.00810-19. doi: 10.1128/JVI.00810.
    PubMed     Abstract available


  123. SLIVA K, Martin J, von Rhein C, Herrmann T, et al
    Interference with SAMHD1 restores late gene expression of modified vaccinia virus Ankara (MVA) in human dendritic cells and abrogates type I interferon expression.
    J Virol. 2019 Aug 28. pii: JVI.01097-19. doi: 10.1128/JVI.01097.
    PubMed     Abstract available


  124. LI SS, Gilbert PB, Carpp LN, Pyo CW, et al
    Fc gamma receptor polymorphisms modulated the vaccine effect on HIV-1 risk in the HVTN 505 HIV vaccine trial.
    J Virol. 2019 Aug 21. pii: JVI.02041-18. doi: 10.1128/JVI.02041.
    PubMed     Abstract available


  125. HENRY C, Palm AE, Utset HA, Huang M, et al
    Monoclonal antibody responses after recombinant HA vaccine versus subunit inactivated influenza virus vaccine: a comparative study.
    J Virol. 2019 Aug 21. pii: JVI.01150-19. doi: 10.1128/JVI.01150.
    PubMed     Abstract available


  126. ALMOND N, Berry N, Stebbings R, Preston M, et al
    Vaccination of macaques with DNA followed by adenoviral vectors encoding SIV gag alone delays infection by repeated mucosal challenge with SIV.
    J Virol. 2019 Aug 14. pii: JVI.00606-19. doi: 10.1128/JVI.00606.
    PubMed     Abstract available


  127. DHAKAL S, Klein SL
    Host factors impact vaccine efficacy: implications for seasonal and universal influenza vaccine programs.
    J Virol. 2019 Aug 7. pii: JVI.00797-19. doi: 10.1128/JVI.00797.
    PubMed     Abstract available


  128. DU C, Duan Y, Wang X, Lin Y, et al
    Attenuation of equine lentivirus alters mitochondrial protein expression profile from inflammation to apoptosis.
    J Virol. 2019 Aug 7. pii: JVI.00653-19. doi: 10.1128/JVI.00653.
    PubMed     Abstract available


  129. WONG YC, Croft S, Smith SA, Lin LCW, et al
    Vaccinia Virus Strain MVA can Induce Optimal CD8(+) T cell responses to Directly Primed Antigens Depending on Vaccine Design.
    J Virol. 2019 Aug 2. pii: JVI.01154-19. doi: 10.1128/JVI.01154.
    PubMed     Abstract available


  130. HRYCAK CP, Windmann S, Bayer W
    Comparative evaluation of the vaccine efficacy of three adenovirus-based vector types in the Friend retrovirus infection model.
    J Virol. 2019 Aug 2. pii: JVI.01155-19. doi: 10.1128/JVI.01155.
    PubMed     Abstract available


  131. GACH JS, Mara KJV, LaBranche CC, van Gils MJ, et al
    Antibody responses elicited by immunization with BG505 trimer-immune complexes.
    J Virol. 2019 Aug 2. pii: JVI.01188-19. doi: 10.1128/JVI.01188.
    PubMed     Abstract available


  132. BROECKER F, Zheng A, Suntrongwong N, Sun W, et al
    Extending the stalk enhances immunogenicity of the influenza virus neuraminidase.
    J Virol. 2019 Aug 2. pii: JVI.00840-19. doi: 10.1128/JVI.00840.
    PubMed     Abstract available


    July 2019
  133. RICO AB, Wang Z, Olson AT, Linville AC, et al
    The Vaccinia B1 and Cellular VRK2 Kinases Promote Vaccinia Replication Factory Formation through Phosphorylation Dependent Inhibition of Vaccinia B12.
    J Virol. 2019 Jul 24. pii: JVI.00855-19. doi: 10.1128/JVI.00855.
    PubMed     Abstract available


  134. STYLES TM, Gangadhara S, Reddy PBJ, Hicks S, et al
    HIV C.1086 Envelope Gp140 Protein Boosts Following DNA/MVA Vaccination Fail to Enhance Heterologous Anti-V1V2 Antibody Response and Protection Against Clade C SHIV Challenge.
    J Virol. 2019 Jul 24. pii: JVI.00934-19. doi: 10.1128/JVI.00934.
    PubMed     Abstract available


  135. RATTAN A, Richards KA, Knowlden ZAG, Sant AJ, et al
    Protein vaccination directs the CD4+ T cell response towards shared protective epitopes that can be recalled after influenza infection.
    J Virol. 2019 Jul 24. pii: JVI.00947-19. doi: 10.1128/JVI.00947.
    PubMed     Abstract available


  136. NOTARIO L, Redondo-Anton J, Alari-Pahissa E, Albentosa A, et al
    CD69 targeting enhances anti-Vaccinia virus immunity.
    J Virol. 2019 Jul 17. pii: JVI.00553-19. doi: 10.1128/JVI.00553.
    PubMed     Abstract available


  137. ABDULHAQQ SA, Wu H, Schell JB, Hammond KB, et al
    Vaccine-mediated Inhibition of the Transporter Associated with Antigen Processing is Insufficient to Induce MHC-E Restricted CD8+ T cells in Nonhuman Primates.
    J Virol. 2019 Jul 17. pii: JVI.00592-19. doi: 10.1128/JVI.00592.
    PubMed     Abstract available


  138. REY LM, Gil JA, Mateus J, Rodriguez LS, et al
    LAP(+) cells modulate protection induced by oral vaccination with Rhesus Rotavirus in a neonatal mouse model.
    J Virol. 2019 Jul 10. pii: JVI.00882-19. doi: 10.1128/JVI.00882.
    PubMed     Abstract available


  139. MEKONNEN ZA, Grubor-Bauk B, English K, Leung P, et al
    Single dose vaccination with a hepatotropic Adeno-associated virus (AAV) efficiently localises T cell immunity in the liver with the potential to confer rapid protection against hepatitis C virus (HCV).
    J Virol. 2019 Jul 10. pii: JVI.00202-19. doi: 10.1128/JVI.00202.
    PubMed     Abstract available


  140. SHEPHERD N, Lan J, Li W, Rane S, et al
    Primary human B cells at different differentiation and maturation stages exhibit distinct susceptibilities to vaccinia virus binding and infection.
    J Virol. 2019 Jul 10. pii: JVI.00973-19. doi: 10.1128/JVI.00973.
    PubMed     Abstract available


  141. LI X, Gao Y, Ye Z
    A Single Amino Acid Substitution at Residue 218 of Hemagglutinin Improves the Growth of Influenza A(H7N9) Candidate Vaccine Viruses.
    J Virol. 2019 Jul 3. pii: JVI.00570-19. doi: 10.1128/JVI.00570.
    PubMed     Abstract available


  142. CARRAU L, Rezelj VV, Noval MG, Levi LI, et al
    Chikungunya virus vaccine candidates with decreased mutational robustness are attenuated in vivo and have compromised transmissibility.
    J Virol. 2019 Jul 3. pii: JVI.00775-19. doi: 10.1128/JVI.00775.
    PubMed     Abstract available


    June 2019
  143. ALFAJARO MM, Kim JY, Barbe L, Cho EH, et al
    Dual Recognition of Sialic Acid and alphaGal Epitopes by the VP8* Domains of the Bovine Rotavirus G6P[5] WC3 and of Its Mono-reassortant G4P[5] RotaTeq Vaccine Strains.
    J Virol. 2019 Jun 26. pii: JVI.00941-19. doi: 10.1128/JVI.00941.
    PubMed     Abstract available


  144. PASIN C, Balelli I, Van Effelterre T, Bockstal V, et al
    Dynamics of the humoral immune response to a prime-boost Ebola vaccine: quantification and sources of variation.
    J Virol. 2019 Jun 26. pii: JVI.00579-19. doi: 10.1128/JVI.00579.
    PubMed     Abstract available


  145. ROY S, Coulon PG, Prakash S, Srivastava R, et al
    Blockade of PD-1 and LAG-3 Immune Checkpoints Combined with Vaccination Restore the Function of Anti-Viral Tissue-Resident CD8(+) TRM Cells and Reduce Ocular Herpes Simplex Infection and Disease in HLA Transgenic Rabbits.
    J Virol. 2019 Jun 19. pii: JVI.00827-19. doi: 10.1128/JVI.00827.
    PubMed     Abstract available


  146. TAI W, Chen J, Zhao G, Geng Q, et al
    Rational design of Zika virus subunit vaccine with enhanced efficacy.
    J Virol. 2019 Jun 12. pii: JVI.02187-18. doi: 10.1128/JVI.02187.
    PubMed     Abstract available


  147. LI N, Zhang YN, Deng CL, Shi PY, et al
    Replication-defective West Nile virus with NS1 deletion as a new vaccine platform for flavivirus.
    J Virol. 2019 Jun 12. pii: JVI.00720-19. doi: 10.1128/JVI.00720.
    PubMed     Abstract available


  148. ZOLLA-PAZNER S, Gilbert PB
    REVISITING THE CORRELATE OF REDUCED HIV INFECTION RISK IN THE RV144 VACCINE TRIAL.
    J Virol. 2019 Jun 12. pii: JVI.00629-19. doi: 10.1128/JVI.00629.
    PubMed     Abstract available


  149. LEHMANN C, Falk JJ, Buscher N, Penner I, et al
    Dense bodies of a gH/gL/UL128-131 pentamer repaired Towne strain of human cytomegalovirus induce an enhanced neutralizing antibody response.
    J Virol. 2019 Jun 12. pii: JVI.00931-19. doi: 10.1128/JVI.00931.
    PubMed     Abstract available


  150. KIM JI, Lee S, Lee GY, Park S, et al
    Novel small molecule targeting the hemagglutinin stalk of influenza viruses.
    J Virol. 2019 Jun 5. pii: JVI.00878-19. doi: 10.1128/JVI.00878.
    PubMed     Abstract available


    May 2019
  151. HOU Y, Ke H, Kim J, Yoo D, et al
    Engineering a live attenuated PEDV vaccine candidate via inactivation of the viral 2'-O methyltransferase and the endocytosis signal of the spike protein.
    J Virol. 2019 May 22. pii: JVI.00406-19. doi: 10.1128/JVI.00406.
    PubMed     Abstract available


  152. MEADE N, King M, Munger J, Walsh D, et al
    mTOR dysregulation by vaccinia virus F17 controls multiple processes with varying roles in infection.
    J Virol. 2019 May 22. pii: JVI.00784-19. doi: 10.1128/JVI.00784.
    PubMed     Abstract available


  153. WEINBERG A, Pang L, Johnson MJ, Caldas Y, et al
    The Effect of Age on the Immunogenicity of the Live Attenuated Zoster Vaccine Is Predicted by Baseline Regulatory T Cells and VZV-Specific T Cell Immunity.
    J Virol. 2019 May 15. pii: JVI.00305-19. doi: 10.1128/JVI.00305.
    PubMed     Abstract available


  154. ZHANG YN, Deng CL, Li JQ, Li N, et al
    Infectious Chikungunya Virus with a Complete Capsid Deletion: a New Approach for CHIKV Vaccine.
    J Virol. 2019 May 15. pii: JVI.00504-19. doi: 10.1128/JVI.00504.
    PubMed     Abstract available


  155. JONES DI, Pollara JJ, Johnson-Weaver BT, LaBranche CC, et al
    Optimized Mucosal MVA Prime/Soluble gp120 Boost Vaccination Regimen Induces Similar Antibody Responses as an Intramuscular Regimen.
    J Virol. 2019 May 8. pii: JVI.00475-19. doi: 10.1128/JVI.00475.
    PubMed     Abstract available


  156. MCGINNES CULLEN L, Schmidt MR, Morrison TG
    Effect of Previous Respiratory Syncytial Virus Infection on Murine Immune Responses to F and G Protein-Containing Virus-Like Particles.
    J Virol. 2019;93.
    PubMed     Abstract available


    April 2019
  157. GOFFIN E, Javaux J, Destexhe E, Pretto CD, et al
    Oral vaccination with replication-competent adenovirus in mice reveals the dissemination of the viral vaccine beyond the gastrointestinal tract.
    J Virol. 2019 Apr 17. pii: JVI.00237-19. doi: 10.1128/JVI.00237.
    PubMed     Abstract available


  158. PANT A, Cao S, Yang Z
    Asparagine is a critical limiting metabolite for vaccinia virus protein synthesis during glutamine deprivation.
    J Virol. 2019 Apr 17. pii: JVI.01834-18. doi: 10.1128/JVI.01834.
    PubMed     Abstract available


  159. CALATAYUD O, Esperon F, Cleaveland S, Biek R, et al
    Carnivore parvovirus ecology in the Serengeti ecosystem: vaccine strains circulating and new host species identified.
    J Virol. 2019 Apr 17. pii: JVI.02220-18. doi: 10.1128/JVI.02220.
    PubMed     Abstract available


  160. LUTEIJN RD, van Diemen F, Blomen VA, Boer IGJ, et al
    A genome-wide haploid genetic screen identifies heparan sulfate-associated genes and the macropinocytosis modulator TMED10 as factors supporting vaccinia virus infection.
    J Virol. 2019 Apr 17. pii: JVI.02160-18. doi: 10.1128/JVI.02160.
    PubMed     Abstract available


  161. TSAI YH, Huang SW, Hsieh WS, Cheng CK, et al
    Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next Generation Vaccine Candidate.
    J Virol. 2019 Apr 17. pii: JVI.02308-18. doi: 10.1128/JVI.02308.
    PubMed     Abstract available


  162. BORENSTEIN-KATZ A, Shulman A, Hamawi H, Leitner O, et al
    Differential Antibody-Based Immune Response against Isolated GP1 Receptor-Binding Domains from Lassa and Junin Viruses.
    J Virol. 2019;93.
    PubMed     Abstract available


  163. SUN W, Kirkpatrick E, Ermler M, Nachbagauer R, et al
    Development of Influenza B Universal Vaccine Candidates using the "Mosaic" Hemagglutinin Approach.
    J Virol. 2019 Apr 3. pii: JVI.00333-19. doi: 10.1128/JVI.00333.
    PubMed     Abstract available


    March 2019
  164. KLEINPETER P, Remy-Ziller C, Winter E, Gantzer M, et al
    By binding CD80 and CD86, the vaccinia virus' M2 protein blocks their interactions with both CD28 and CTLA4 and potentiates CD80's binding to PD-L1.
    J Virol. 2019 Mar 27. pii: JVI.00207-19. doi: 10.1128/JVI.00207.
    PubMed     Abstract available


  165. POLLARA J, Jones DI, Huffman T, Edwards RW, et al
    Bridging vaccine-induced HIV-1 neutralizing and effector antibody responses in rabbit and rhesus macaque animal models.
    J Virol. 2019 Mar 6. pii: JVI.02119-18. doi: 10.1128/JVI.02119.
    PubMed     Abstract available


  166. MATCHETT WE, Anguiano-Zarate SS, Nehete PN, Shelton K, et al
    Divergent HIV-1 Directed Immune Responses Generated by Systemic and Mucosal Immunization with Replicating Single-Cycle Adenoviruses in Rhesus Macaques.
    J Virol. 2019 Mar 6. pii: JVI.02016-18. doi: 10.1128/JVI.02016.
    PubMed     Abstract available


  167. WANG H, Wong G, Zhu W, He S, et al
    Equine-Origin Immunoglobulin Fragments Protect Nonhuman Primates from Ebola Virus Disease.
    J Virol. 2019;93.
    PubMed     Abstract available


  168. GROSS DA, Ghenassia A, Bartolo L, Urbain D, et al
    Cross-Presentation of Skin-Targeted Recombinant Adeno-associated Virus 2/1 Transgene Induces Potent Resident Memory CD8(+) T Cell Responses.
    J Virol. 2019;93.
    PubMed     Abstract available


    February 2019
  169. PALLETT MA, Ren H, Zhang RY, Scutts SR, et al
    Vaccinia virus BBK E3 ligase adaptor A55 targets importin-dependent NF-kappaB activation and inhibits CD8(+) T-cell memory.
    J Virol. 2019 Feb 27. pii: JVI.00051-19. doi: 10.1128/JVI.00051.
    PubMed     Abstract available


  170. SRIVASTAVA R, Roy S, Coulon PA, Vahed H, et al
    Therapeutic Mucosal Vaccination of HSV-2 Infected Guinea Pigs with the Ribonucleotide Reductase 2 (RR2) Protein Boosts Antiviral Neutralizing Antibodies and Tissue-Resident CD4(+) and CD8(+) TRM Cells Associated with Protection Against Recurrent Genit
    J Virol. 2019 Feb 20. pii: JVI.02309-18. doi: 10.1128/JVI.02309.
    PubMed     Abstract available


  171. VAN DIEPEN MT, Chapman R, Douglass N, Galant S, et al
    Prime boost immunisations with DNA, MVA and protein-based vaccines elicit robust HIV-1, Tier 2 neutralizing antibodies against the CAP256 superinfecting virus.
    J Virol. 2019 Feb 13. pii: JVI.02155-18. doi: 10.1128/JVI.02155.
    PubMed     Abstract available


  172. WU Q, Rivailler P, Xu S, Xu W, et al
    Comparison of the whole genome sequence of an Oka varicella vaccine from China with other Oka vaccine strains reveals sites putatively critical for vaccine efficacy.
    J Virol. 2019 Feb 6. pii: JVI.02281-18. doi: 10.1128/JVI.02281.
    PubMed     Abstract available


    January 2019
  173. TAY MZ, Kunz EL, Deal A, Zhang L, et al
    Rare Detection of Antiviral Functions of Polyclonal IgA Isolated from Plasma and Breast Milk Compartments in HIV-1 Chronically Infected Women.
    J Virol. 2019 Jan 30. pii: JVI.02084-18. doi: 10.1128/JVI.02084.
    PubMed     Abstract available


  174. ZOU C, Murakoshi H, Kuse N, Akahoshi T, et al
    Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens.
    J Virol. 2019 Jan 23. pii: JVI.02142-18. doi: 10.1128/JVI.02142.
    PubMed     Abstract available


  175. MARIN MQ, Perez P, Ljungberg K, Sorzano COS, et al
    Potent Anti-Hepatitis C (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-launched RNA Replicons and MVA-HCV.
    J Virol. 2019 Jan 23. pii: JVI.00055-19. doi: 10.1128/JVI.00055.
    PubMed     Abstract available


  176. BURTON S, Spicer LM, Charles TP, Gangadhara S, et al
    Clade C HIV-1 envelope vaccination regimens differ in their ability to elicit antibodies with moderate neutralization breadth against genetically diverse tier 2 HIV-1 envelope variants.
    J Virol. 2019 Jan 16. pii: JVI.01846-18. doi: 10.1128/JVI.01846.
    PubMed     Abstract available


  177. LI ZT, Zarnitsyna VI, Lowen AC, Weissman D, et al
    Why Are CD8 T Cell Epitopes of Human Influenza A Virus Conserved?
    J Virol. 2019 Jan 9. pii: JVI.01534-18. doi: 10.1128/JVI.01534.
    PubMed     Abstract available


  178. ARUNKUMAR GA, Ioannou A, Wohlbold TJ, Meade P, et al
    Broadly cross-reactive, non-neutralizing antibodies against the influenza B virus hemagglutinin demonstrate effector function dependent protection against lethal viral challenge in mice.
    J Virol. 2019 Jan 9. pii: JVI.01696-18. doi: 10.1128/JVI.01696.
    PubMed     Abstract available


    December 2018
  179. DE FREITAS LFD, Oliveira RP, Miranda MCG, Rocha RP, et al
    The virulence of different Vaccinia virus strains is directly proportional to their ability in down modulating specific cell-mediated immune compartments in vivo.
    J Virol. 2018 Dec 19. pii: JVI.02191-18. doi: 10.1128/JVI.02191.
    PubMed     Abstract available


  180. OBADAN AO, Santos J, Ferreri L, Thompson AJ, et al
    Flexibility in vitro of amino acid 226 in the receptor-binding site of an H9 subtype influenza A virus and its effect in vivo on virus replication, tropism, and transmission.
    J Virol. 2018 Dec 19. pii: JVI.02011-18. doi: 10.1128/JVI.02011.
    PubMed     Abstract available


  181. KESHWARA R, Hagen KR, Abreu-Mota T, Papaneri AB, et al
    A Recombinant Rabies Virus Expressing the Marburg Virus Glycoprotein is Dependent Upon ADCC for Protection Against Marburg Virus Disease in a Murine Model.
    J Virol. 2018 Dec 19. pii: JVI.01865-18. doi: 10.1128/JVI.01865.
    PubMed     Abstract available


  182. MOSHKANI S, Chiale C, Lang SM, Rose JK, et al
    A highly attenuated vesicular stomatitis virus-based vaccine platform controls HBV replication in mouse models of hepatitis B.
    J Virol. 2018 Dec 12. pii: JVI.01586-18. doi: 10.1128/JVI.01586.
    PubMed     Abstract available


  183. MARTINS MA, Gonzalez-Nieto L, Shin YC, Domingues A, et al
    Vaccine-induced T-cell responses do not predict the rate of acquisition after repeated intrarectal SIVmac239 challenges in Mamu-B*08+ rhesus macaques.
    J Virol. 2018 Dec 12. pii: JVI.01626-18. doi: 10.1128/JVI.01626.
    PubMed     Abstract available


  184. DENNIS M, Eudailey J, Pollara J, McMillan AS, et al
    Co-administration of CH31 broadly neutralizing antibody does not affect development of vaccine-induced anti-HIV-1 envelope antibody responses in infant Rhesus macaques.
    J Virol. 2018 Dec 12. pii: JVI.01783-18. doi: 10.1128/JVI.01783.
    PubMed     Abstract available


  185. CHEA LS, Wyatt LS, Gangadhara S, Moss B, et al
    Novel MVA Vector Expressing Anti-apoptotic Gene B13R Delays Apoptosis and Enhances Humoral Responses.
    J Virol. 2018 Dec 12. pii: JVI.01648-18. doi: 10.1128/JVI.01648.
    PubMed     Abstract available


  186. KIMBLE JB, Malherbe DC, Meyer M, Gunn BM, et al
    ANTIBODY-MEDIATED PROTECTIVE MECHANISMS INDUCED BY A TRIVALENT PARAINFLUENZA-VECTORED EBOLAVIRUS VACCINE.
    J Virol. 2018 Dec 5. pii: JVI.01845-18. doi: 10.1128/JVI.01845.
    PubMed     Abstract available


  187. NELSON CS, Cruz DV, Su M, Xie G, et al
    Intrahost dynamics of human cytomegalovirus variants acquired by seronegative glycoprotein B vaccinees.
    J Virol. 2018 Dec 5. pii: JVI.01695-18. doi: 10.1128/JVI.01695.
    PubMed     Abstract available


  188. CHEN YQ, Lan LY, Huang M, Henry C, et al
    Hemagglutinin stalk-reactive antibodies interfere with influenza virus neuraminidase activity by steric hindrance.
    J Virol. 2018 Dec 5. pii: JVI.01526-18. doi: 10.1128/JVI.01526.
    PubMed     Abstract available


    November 2018
  189. RINGE RP, Pugach P, Cottrell CA, LaBranche CC, et al
    Closing and opening holes in the glycan shield of HIV-1 envelope glycoprotein SOSIP trimers can redirect the neutralizing antibody response to the newly unmasked epitopes.
    J Virol. 2018 Nov 28. pii: JVI.01656-18. doi: 10.1128/JVI.01656.
    PubMed     Abstract available


  190. MONTICELLI SR, Earley AK, Tate J, Ward BM, et al
    The Ectodomain of the Vaccinia Virus Glycoprotein A34 is Required for Cell Binding by Extracellular Virions and Contains a Large Region Capable of Interaction with the Glycoprotein B5.
    J Virol. 2018 Nov 21. pii: JVI.01343-18. doi: 10.1128/JVI.01343.
    PubMed     Abstract available


  191. HELMOLD HAIT S, Vargas-Inchaustegui DA, Musich T, Mohanram V, et al
    Early T follicular helper cell responses and germinal center reactions are associated with viremia control in immunized Rhesus macaques.
    J Virol. 2018 Nov 21. pii: JVI.01687-18. doi: 10.1128/JVI.01687.
    PubMed     Abstract available


  192. ASBACH B, Kibler KV, Kostler J, Perdiguero B, et al
    Priming with a potent HIV-1 DNA vaccine frames the quality of immune responses prior to a poxvirus and protein boost.
    J Virol. 2018 Nov 14. pii: JVI.01529-18. doi: 10.1128/JVI.01529.
    PubMed     Abstract available


  193. NURNBERGER C, Bodmer BS, Fiedler AH, Gabriel G, et al
    A measles virus-based vaccine candidate mediates protection against Zika virus in an allogenic mouse pregnancy model.
    J Virol. 2018 Nov 14. pii: JVI.01485-18. doi: 10.1128/JVI.01485.
    PubMed     Abstract available


  194. ALLEN JD, Jang H, DiNapoli J, Kleanthous H, et al
    Elicitation of protective antibodies against 20 years of future H3N2 co-ciruculating influenza virus variants in ferrets preimmune to historical H3N2 influenza viruses.
    J Virol. 2018 Nov 14. pii: JVI.00946-18. doi: 10.1128/JVI.00946.
    PubMed     Abstract available


  195. KIBLER KV, Asbach B, Perdiguero B, Garcia-Arriaza J, et al
    Replication-competent NYVAC-KC yields improved immunogenicity to HIV-1 antigens in rhesus macaques, compared to non-replicating NYVAC.
    J Virol. 2018 Nov 14. pii: JVI.01513-18. doi: 10.1128/JVI.01513.
    PubMed     Abstract available


    October 2018
  196. HUSSAIN S, Turnbull ML, Wise HM, Jagger BW, et al
    Mutation of influenza A virus PA-X decreases pathogenicity in chicken embryos and can increase the yield of reassortant candidate vaccine viruses.
    J Virol. 2018 Oct 31. pii: JVI.01551-18. doi: 10.1128/JVI.01551.
    PubMed     Abstract available


  197. SUN W, Kang DS, Zheng A, Liu STH, et al
    Antibody responses towards the major antigenic sites of influenza B virus hemagglutinin in mice, ferrets and humans.
    J Virol. 2018 Oct 31. pii: JVI.01673-18. doi: 10.1128/JVI.01673.
    PubMed     Abstract available


  198. PRACHANRONARONG KL, Canale AS, Liu P, Somasundaran M, et al
    Mutations in influenza A virus neuraminidase and hemagglutinin confer resistance against a broadly neutralizing hemagglutinin stem antibody.
    J Virol. 2018 Oct 31. pii: JVI.01639-18. doi: 10.1128/JVI.01639.
    PubMed     Abstract available


  199. AN Y, Parsons LM, Jankowska E, Melnyk D, et al
    N-Glycosylation of Seasonal Influenza Vaccine Hemagglutinins: Implication for potency testing and immune processing.
    J Virol. 2018 Oct 24. pii: JVI.01693-18. doi: 10.1128/JVI.01693.
    PubMed     Abstract available


  200. OGDEN KM, Tan Y, Akopov A, Stewart LS, et al
    Multiple introductions and antigenic mismatch with vaccines may contribute to increased predominance of G12P[8] rotaviruses in the United States.
    J Virol. 2018 Oct 17. pii: JVI.01476-18. doi: 10.1128/JVI.01476.
    PubMed     Abstract available


  201. MURAKOSHI H, Kuse N, Akahoshi T, Yu Z, et al
    Broad recognition of circulating HIV-1 by HIV-1-specific CTLs with strong ability to suppress HIV-1 replication.
    J Virol. 2018 Oct 17. pii: JVI.01480-18. doi: 10.1128/JVI.01480.
    PubMed     Abstract available


  202. KINLOCH NN, Lee GQ, Carlson JM, Jin SW, et al
    Genotypic and Mechanistic Characterization of Subtype-specific HIV Adaptation to Host Cellular Immunity.
    J Virol. 2018 Oct 10. pii: JVI.01502-18. doi: 10.1128/JVI.01502.
    PubMed     Abstract available


    September 2018
  203. HODGSON S, Moffat K, Hill H, Flannery JT, et al
    Comparison of the immunogenicity and cross-lineage efficacy of live attenuated peste des petits ruminants virus vaccines PPRV/Nigeria/75/1 and PPRV/Sungri/96.
    J Virol. 2018 Sep 26. pii: JVI.01471-18. doi: 10.1128/JVI.01471.
    PubMed     Abstract available


  204. FREI JC, Wirchnianski AS, Govero J, Vergnolle O, et al
    Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice.
    J Virol. 2018;92.
    PubMed     Abstract available


  205. SIVAN G, Glushakow-Smith SG, Katsafanas GC, Americo JL, et al
    Human host-range restriction of the vaccinia virus C7/K1 double deletion mutant is mediated by an atypical mode of translation inhibition.
    J Virol. 2018 Sep 12. pii: JVI.01329-18. doi: 10.1128/JVI.01329.
    PubMed     Abstract available


  206. PISSANI F, Schulte B, Eller MA, Schultz BT, et al
    Modulation of Vaccine-induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in Humans.
    J Virol. 2018 Sep 12. pii: JVI.01143-18. doi: 10.1128/JVI.01143.
    PubMed     Abstract available


  207. TSAI WY, Chen HL, Tsai JJ, Dejnirattisai W, et al
    Potent neutralizing human monoclonal antibodies preferentially target mature dengue virus particles: implication for novel strategy of dengue vaccine.
    J Virol. 2018 Sep 5. pii: JVI.00556-18. doi: 10.1128/JVI.00556.
    PubMed     Abstract available


  208. DARRICARRERE N, Pougatcheva S, Duan X, Rudicell RS, et al
    Development of a Pan-H1 Influenza Vaccine.
    J Virol. 2018 Sep 5. pii: JVI.01349-18. doi: 10.1128/JVI.01349.
    PubMed     Abstract available


  209. ABENTE EJ, Rajao DS, Santos J, Kaplan BS, et al
    Comparison of adjuvanted-whole inactivated virus and live-attenuated virus vaccines against challenge with contemporary, antigenically distinct swine H3N2 influenza A viruses.
    J Virol. 2018 Sep 5. pii: JVI.01323-18. doi: 10.1128/JVI.01323.
    PubMed     Abstract available


  210. DAVIDO DJ, Tu EM, Wang H, Korom M, et al
    Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.
    J Virol. 2018;92.
    PubMed     Abstract available


  211. BROCK LG, Liu X, Liang B, Lingemann M, et al
    Murine Pneumonia Virus Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus from an Added Gene Is Highly Attenuated and Immunogenic in Rhesus Macaques.
    J Virol. 2018;92.
    PubMed     Abstract available


    August 2018
  212. WAN Z, Cardenas Garcia S, Liu J, Santos J, et al
    An alternative strategy as a quadrivalent live attenuated influenza virus vaccine.
    J Virol. 2018 Aug 22. pii: JVI.01025-18. doi: 10.1128/JVI.01025.
    PubMed     Abstract available


  213. SHAN C, Xie X, Zou J, Zust R, et al
    Using a virion assembly-defective dengue virus as a vaccine approach.
    J Virol. 2018 Aug 15. pii: JVI.01002-18. doi: 10.1128/JVI.01002.
    PubMed     Abstract available


  214. BLOOM DC, Tran RK, Feller J, Voellmy R, et al
    Immunization by Replication-Competent Controlled Herpesvirus Vectors.
    J Virol. 2018;92.
    PubMed     Abstract available


  215. MARIN-LOPEZ A, Calvo-Pinilla E, Barriales D, Lorenzo G, et al
    CD8 T Cell Responses to an Immunodominant Epitope within the Nonstructural Protein NS1 Provide Wide Immunoprotection against Bluetongue Virus in IFNAR(-/-) Mice.
    J Virol. 2018;92.
    PubMed     Abstract available


  216. PHILLIPS B, Van Rompay KKA, Rodriguez-Nieves J, Lorin C, et al
    Adjuvant-dependent enhancement of HIV Env-specific antibody responses in infant rhesus macaques.
    J Virol. 2018 Aug 8. pii: JVI.01051-18. doi: 10.1128/JVI.01051.
    PubMed     Abstract available


  217. PERMAR SR, Schleiss MR, Plotkin SA
    Reply to Gantt et al., "Higher Expectations for a Vaccine To Prevent Congenital Cytomegalovirus Infection".
    J Virol. 2018;92.
    PubMed    


  218. GANTT S, Marchant A, Boppana SB
    Higher Expectations for a Vaccine To Prevent Congenital Cytomegalovirus Infection.
    J Virol. 2018;92.
    PubMed    


  219. KIENER R, Fleischmann M, Wiegand MA, Lemmermann NAW, et al
    Efficient Delivery of Human Cytomegalovirus T Cell Antigens by Attenuated Sendai Virus Vectors.
    J Virol. 2018;92.
    PubMed     Abstract available


  220. KIM YJ, Kim KH, Ko EJ, Kim MC, et al
    Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain Specific HA or Cross Protective M2e vaccination.
    J Virol. 2018 Aug 1. pii: JVI.00969-18. doi: 10.1128/JVI.00969.
    PubMed     Abstract available


    July 2018
  221. STUART CA, Zhivkoplias EK, Senkevich TG, Wyatt LS, et al
    RNA polymerase mutations selected during experimental evolution enhance replication of a hybrid vaccinia virus with an intermediate transcription factor subunit replaced by the myxoma virus ortholog.
    J Virol. 2018 Jul 25. pii: JVI.01089-18. doi: 10.1128/JVI.01089.
    PubMed     Abstract available


  222. CHIUPPESI F, Nguyen J, Park S, Contreras H, et al
    Multi-Antigenic Modified Vaccinia Ankara Vaccine Vectors to Elicit Potent Humoral and Cellular Immune Reponses Against Human Cytomegalovirus in Mice.
    J Virol. 2018 Jul 25. pii: JVI.01012-18. doi: 10.1128/JVI.01012.
    PubMed     Abstract available


  223. BROECKER F, Liu STH, Sun W, Krammer F, et al
    Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice.
    J Virol. 2018 Jul 25. pii: JVI.01100-18. doi: 10.1128/JVI.01100.
    PubMed     Abstract available


  224. MILLER-NOVAK LK, Das J, Musich TA, Demberg T, et al
    Analysis of complement-mediated lysis of SIV and SIV-infected cells reveals sex differences in vaccine-induced immune responses in Rhesus macaques.
    J Virol. 2018 Jul 18. pii: JVI.00721-18. doi: 10.1128/JVI.00721.
    PubMed     Abstract available


  225. CHAN KW, Pan R, Costa M, Gorny MK, et al
    Structural Comparison of Human Anti-HIV-1 gp120 V3 MAbs of the Same Gene Usage Induced by Vaccination and Chronic Infection.
    J Virol. 2018 Jul 11. pii: JVI.00641-18. doi: 10.1128/JVI.00641.
    PubMed     Abstract available


  226. MEHTA N, Enwere EK, Dos Santos T, Saffran HA, et al
    Expression of the vaccinia virus anti-apoptotic F1 protein is blocked by PKR in the absence of the viral E3 protein.
    J Virol. 2018 Jul 11. pii: JVI.01167-18. doi: 10.1128/JVI.01167.
    PubMed     Abstract available


  227. HOVANESSIAN AG, Soundaramourty C, Benferhat R, Le Grand R, et al
    Vaccination with the conserved caveolin-1 binding motif in HIV-1 glycoprotein gp41 delays the onset of viral infection and provides partial protection in SHIV-challenged cynomolgus macaques.
    J Virol. 2018 Jul 5. pii: JVI.00370-18. doi: 10.1128/JVI.00370.
    PubMed     Abstract available


  228. MENACHERY VD, Gralinski LE, Mitchell HD, Dinnon KH 3rd, et al
    Combination attenuation offers strategy for live-attenuated coronavirus vaccines.
    J Virol. 2018 Jul 5. pii: JVI.00710-18. doi: 10.1128/JVI.00710.
    PubMed     Abstract available


  229. CAO QM, Ni YY, Cao D, Tian D, et al
    Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Membrane-Bound Interleukin-15 as an Immunomodulatory Adjuvant Enhances NK and gammadelta T Cell Responses and Confers Heterologous Protection.
    J Virol. 2018;92.
    PubMed     Abstract available


    June 2018
  230. ZHANG M, Sun Y, Chen W, Bu Z, et al
    The 135 gene of goatpox virus encodes an inhibitor of nuclear factor-kappaB and apoptosis and may serve as an improved insertion site to generate vectored live vaccine.
    J Virol. 2018 Jun 27. pii: JVI.00190-18. doi: 10.1128/JVI.00190.
    PubMed     Abstract available


  231. VIKTOROVA EG, Khattar SK, Kouiavskaia D, Laassri M, et al
    Newcastle Disease Virus-Based Vectored Vaccine against Poliomyelitis.
    J Virol. 2018 Jun 20. pii: JVI.00976-18. doi: 10.1128/JVI.00976.
    PubMed     Abstract available


  232. LI P, Ke X, Wang T, Tan Z, et al
    Zika Virus Attenuation by Codon Pair Deoptimization Induces Sterilizing Immunity in Mouse Models.
    J Virol. 2018 Jun 20. pii: JVI.00701-18. doi: 10.1128/JVI.00701.
    PubMed     Abstract available


  233. WALZ L, Kays SK, Zimmer G, von Messling V, et al
    Sialidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    J Virol. 2018 Jun 20. pii: JVI.01006-18. doi: 10.1128/JVI.01006.
    PubMed     Abstract available


  234. KHAN AA, Srivastava R, Vahed H, Roy S, et al
    Human Asymptomatic Epitope Peptide/CXCL10-Based Prime/Pull Vaccine Induces Herpes Simplex Virus-Specific Gamma Interferon-Positive CD107(+) CD8(+) T Cells That Infiltrate the Cornea and Trigeminal Ganglia of Humanized HLA Transgenic Rabbits and Protec
    J Virol. 2018 Jun 13. pii: JVI.00535-18. doi: 10.1128/JVI.00535.
    PubMed     Abstract available


  235. MARTINS MA, Tully DC, Pedreno-Lopez N, von Bredow B, et al
    Mamu-B*17+ rhesus macaques vaccinated with env, vif, and nef manifest early control of SIVmac239 replication.
    J Virol. 2018 Jun 6. pii: JVI.00690-18. doi: 10.1128/JVI.00690.
    PubMed     Abstract available


  236. IAMPIETRO MJ, Larocca RA, Provine NM, Abbink P, et al
    Immunogenicity and Cross-Reactivity of Rhesus Adenoviral Vectors.
    J Virol. 2018;92.
    PubMed     Abstract available


    May 2018
  237. SINGH S, Ramirez-Salazar EG, Doueiri R, Valentin A, et al
    Control of Heterologous SIVsmE660 infection by DNA and Protein Co-immunization Regimens Combined with Different Toll-like Receptor-4 (TLR-4) Based Adjuvants in Macaques.
    J Virol. 2018 May 23. pii: JVI.00281-18. doi: 10.1128/JVI.00281.
    PubMed     Abstract available


  238. SULLIVAN NL, Reuter-Monslow MA, Sei J, Durr E, et al
    Breadth and functionality of varicella zoster virus glycoprotein-specific antibodies identified after Zostavax vaccination in humans.
    J Virol. 2018 May 9. pii: JVI.00269-18. doi: 10.1128/JVI.00269.
    PubMed     Abstract available


  239. ELSAYED H, Nabi G, McKinstry WJ, Khoo KK, et al
    Intrastructural Help: Harnessing T-Helper Cells Induced by Licensed Vaccines for Improvement of HIV Env Antibody Responses to Virus-Like Particle Vaccines.
    J Virol. 2018 May 9. pii: JVI.00141-18. doi: 10.1128/JVI.00141.
    PubMed     Abstract available


    April 2018
  240. SANTOS ROCHA C, Hirao LA, Weber MG, Mendez-Lagares G, et al
    Subclinical cytomegalovirus infection associates with altered host immunity, gut microbiota and vaccine responses.
    J Virol. 2018 Apr 18. pii: JVI.00167-18. doi: 10.1128/JVI.00167.
    PubMed     Abstract available


  241. OZOROWSKI G, Cupo A, Golabek M, LoPiccolo M, et al
    Effects of adjuvants on HIV-1 envelope glycoprotein SOSIP trimers in vitro.
    J Virol. 2018 Apr 18. pii: JVI.00381-18. doi: 10.1128/JVI.00381.
    PubMed     Abstract available


  242. BRICAULT CA, Kovacs JM, Badamchi-Zadeh A, McKee K, et al
    Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea Pigs.
    J Virol. 2018 Apr 11. pii: JVI.00369-18. doi: 10.1128/JVI.00369.
    PubMed     Abstract available


    March 2018
  243. CARNEC X, Mateo M, Page A, Reynard S, et al
    A vaccine platform against arenaviruses based on a recombinant hyper-attenuated Mopeia virus expressing heterologous glycoproteins.
    J Virol. 2018 Mar 28. pii: JVI.02230-17. doi: 10.1128/JVI.02230.
    PubMed     Abstract available


  244. BARBAN V, Mantel N, De Montfort A, Pagnon A, et al
    Improvement of Dengue Non-Human Primate Model via a Reverse Translational Approach Based on Dengue Vaccine Clinical Efficacy Data against Dengue 2 and Dengue 4.
    J Virol. 2018 Mar 28. pii: JVI.00440-18. doi: 10.1128/JVI.00440.
    PubMed     Abstract available


  245. WANG W, Song HS, Keller PW, Alvarado-Facundo E, et al
    Conformational stability of the hemagglutinin of H5N1 influenza A viruses influences susceptibility to broadly neutralizing stem antibodies.
    J Virol. 2018 Mar 28. pii: JVI.00247-18. doi: 10.1128/JVI.00247.
    PubMed     Abstract available


  246. ALJURAYYAN A, Puksuriwong S, Ahmed M, Sharma R, et al
    Activation and induction of antigen-specific T follicular helper cells (TFH) play a critical role in LAIV-induced human mucosal anti-influenza antibody response.
    J Virol. 2018 Mar 21. pii: JVI.00114-18. doi: 10.1128/JVI.00114.
    PubMed     Abstract available


  247. AGNIHOTHRAM S, Menachery VD, Yount BL Jr., Lindesmith LC, et al
    Development of a Broadly Accessible VEE Replicon Particle Vaccine Platform.
    J Virol. 2018 Mar 14. pii: JVI.00027-18. doi: 10.1128/JVI.00027.
    PubMed     Abstract available


  248. BRYK P, Brewer MG, Ward BM
    Vaccinia virus phospholipase protein F13 promotes the rapid entry of extracellular virions into cells.
    J Virol. 2018 Mar 14. pii: JVI.02154-17. doi: 10.1128/JVI.02154.
    PubMed     Abstract available


  249. LAW JLM, Logan M, Wong J, Kundu J, et al
    Role of the E2 hypervariable region (HVR1) in the immunogenicity of a recombinant HCV vaccine.
    J Virol. 2018 Mar 14. pii: JVI.02141-17. doi: 10.1128/JVI.02141.
    PubMed     Abstract available


  250. BLASS E, Aid M, Martinot AJ, Larocca RA, et al
    Adenovirus vector vaccination impacts NK cell rheostat function following LCMV infection.
    J Virol. 2018 Mar 7. pii: JVI.02103-17. doi: 10.1128/JVI.02103.
    PubMed     Abstract available


  251. LAZARO-FRIAS A, Gomez-Medina S, Sanchez-Sampedro L, Ljungberg K, et al
    Distinct Immunogenicity and Efficacy of Poxvirus-based Vaccine Candidates against Ebola Virus expressing GP and VP40 Proteins.
    J Virol. 2018 Mar 7. pii: JVI.00363-18. doi: 10.1128/JVI.00363.
    PubMed     Abstract available


  252. WAN Y, Kang G, Sreenivasan C, Daharsh L, et al
    A DNA vaccine expressing consensus hemagglutinin-esterase fusion protein protected guinea pigs from infection by two lineages of influenza D virus.
    J Virol. 2018 Mar 7. pii: JVI.00110-18. doi: 10.1128/JVI.00110.
    PubMed     Abstract available


    February 2018
  253. GU J, Hardy J, Boo I, Vietheer P, et al
    Escape of Hepatitis C virus from epitope I neutralization increases sensitivity of other neutralization epitopes.
    J Virol. 2018 Feb 21. pii: JVI.02066-17. doi: 10.1128/JVI.02066.
    PubMed     Abstract available


  254. POUYANFARD S, Spagnoli G, Bulli L, Balz K, et al
    Minor Capsid Protein L2 Polytope Induces Broad Protection against Oncogenic and Mucosal Human Papillomaviruses.
    J Virol. 2018;92.
    PubMed     Abstract available


  255. LIU R, Moss B
    Vaccinia virus C9 ankyrin-repeat/F-box protein is a newly identified antagonist of the type I interferon-induced antiviral state.
    J Virol. 2018 Feb 14. pii: JVI.00053-18. doi: 10.1128/JVI.00053.
    PubMed     Abstract available


  256. JEGASKANDA S, Mason RD, Andrews SF, Wheatley AK, et al
    Intranasal live influenza vaccine priming elicits localized B cell responses in mediastinal lymph nodes.
    J Virol. 2018 Feb 14. pii: JVI.01970-17. doi: 10.1128/JVI.01970.
    PubMed     Abstract available


  257. LOPES PP, Todorov G, Pham TT, Nesburn AB, et al
    Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8(+) TEM and TRM Cell Responses Against Herpes Infection and Disease(double dagger).
    J Virol. 2018 Feb 7. pii: JVI.02156-17. doi: 10.1128/JVI.02156.
    PubMed     Abstract available


  258. SAUNDERS KO, Santra S, Parks R, Yates NL, et al
    Immunogenicity of NYVAC prime-protein boost HIV-1 envelope vaccination and SHIV challenge of nonhuman primates.
    J Virol. 2018 Feb 7. pii: JVI.02035-17. doi: 10.1128/JVI.02035.
    PubMed     Abstract available


  259. WIJESUNDARA DK, Gummow J, Li Y, Yu W, et al
    Induction of genotype-cross reactive, hepatitis C virus-specific cell mediated immunity in DNA-vaccinated mice.
    J Virol. 2018 Feb 7. pii: JVI.02133-17. doi: 10.1128/JVI.02133.
    PubMed     Abstract available


    January 2018
  260. JANKOVICH JK, Chapman D, Hansen DT, Robida MD, et al
    Immunisation of pigs by DNA prime and recombinant vaccinia virus boost to identify and rank African swine fever virus immunogenic and protective proteins.
    J Virol. 2018 Jan 31. pii: JVI.02219-17. doi: 10.1128/JVI.02219.
    PubMed     Abstract available


  261. YATES NL, deCamp AC, Korber BT, Liao HX, et al
    HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees.
    J Virol. 2018 Jan 31. pii: JVI.01843-17. doi: 10.1128/JVI.01843.
    PubMed     Abstract available


  262. TORRENTS DE LA PENA A, de Taeye SW, Sliepen K, LaBranche CC, et al
    Immunogenicity in rabbits of SOSIP trimers from clades A, B and C, given individually, sequentially or in combinations.
    J Virol. 2018 Jan 24. pii: JVI.01957-17. doi: 10.1128/JVI.01957.
    PubMed     Abstract available


  263. PERMAR SR, Schleiss MR, Plotkin SA
    Advancing our understanding of protective maternal immunity as a guide for development of vaccines to reduce congenital cytomegalovirus infections.
    J Virol. 2018 Jan 17. pii: JVI.00030-18. doi: 10.1128/JVI.00030.
    PubMed     Abstract available


  264. WILLS S, Hwang KK, Liu P, Dennison SM, et al
    HIV-1 specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galcer Blocking and Phagocytosis.
    J Virol. 2018 Jan 10. pii: JVI.01552-17. doi: 10.1128/JVI.01552.
    PubMed     Abstract available


  265. MOSTAFA HH, Thompson TW, Konen AJ, Haenchen SD, et al
    Herpes Simplex Virus 1 Mutant with Point Mutations in UL39 Is Impaired for Acute Viral Replication in Mice, Establishment of Latency, and Explant-Induced Reactivation.
    J Virol. 2018 Jan 10. pii: JVI.01654-17. doi: 10.1128/JVI.01654.
    PubMed     Abstract available


  266. ABBINK P, Kirilova M, Boyd M, Mercado N, et al
    Rapid Cloning of Novel Rhesus Adenoviral Vaccine Vectors.
    J Virol. 2018 Jan 3. pii: JVI.01924-17. doi: 10.1128/JVI.01924.
    PubMed     Abstract available


  267. XU K, Song Y, Dai L, Zhang Y, et al
    Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage.
    J Virol. 2018 Jan 3. pii: JVI.01722-17. doi: 10.1128/JVI.01722.
    PubMed     Abstract available


    December 2017
  268. ROSTAD CA, Stobart CC, Todd SO, Molina SA, et al
    ENHANCING THE THERMOSTABILITY AND IMMUNOGENICITY OF AN RSV LIVE-ATTENUATED VACCINE BY INCORPORATING UNIQUE RSV LINE19F PROTEIN RESIDUES.
    J Virol. 2017 Dec 20. pii: JVI.01568-17. doi: 10.1128/JVI.01568.
    PubMed     Abstract available


  269. LIANG R, Sun Y, Liu Y, Wang J, et al
    Major histocompatibility complex class I (FLA-E*01801) molecular structure in domestic cats demonstrates species-specific characteristics in presenting viral antigen peptides.
    J Virol. 2017 Dec 20. pii: JVI.01631-17. doi: 10.1128/JVI.01631.
    PubMed     Abstract available


  270. LI C, Zhou H, Zhang H, Wang S, et al
    Bioinformatics Analysis of Differential Innate Immune Signaling in Macrophages by Wild-Type Vaccinia Mature Virus and a Mutant Virus with a Deletion of the A26 Protein.
    J Virol. 2017;91.
    PubMed    


  271. KASANI SK, Cheng HY, Yeh KE, Chang SJ, et al
    Reply to "Bioinformatics Analysis of Differential Innate Immune Signaling in Macrophages by Wild-Type Vaccinia Mature Virus and a Mutant Virus with a Deletion of the A26 Protein".
    J Virol. 2017;91.
    PubMed    


  272. REIS AL, Goatley LC, Jabbar T, Sanchez-Cordon PJ, et al
    Deletion of the African Swine Fever Virus Gene DP148R Does Not Reduce Virus Replication in Culture but Reduces Virus Virulence in Pigs and Induces High Levels of Protection against Challenge.
    J Virol. 2017;91.
    PubMed     Abstract available


  273. JONES AT, Chamcha V, Kesavardhana S, Shen X, et al
    A trimeric HIV-1 envelope gp120 immunogen induces potent and broad anti-V1V2 loop antibodies against HIV-1 in rabbits and rhesus macaques.
    J Virol. 2017 Dec 13. pii: JVI.01796-17. doi: 10.1128/JVI.01796.
    PubMed     Abstract available


  274. CHEN C, Liu L, Xiao Y, Cui S, et al
    Structural insight into a human neutralizing antibody against influenza virus H7N9.
    J Virol. 2017 Dec 6. pii: JVI.01850-17. doi: 10.1128/JVI.01850.
    PubMed     Abstract available


  275. ROYER DJ, Carr DJJ
    Reply to "Highly Efficacious Novel Vaccine, Humoral Immunity, and Ocular Herpes Simplex Virus 1: Reality or Myth?"
    J Virol. 2017;91.
    PubMed    


  276. GHIASI H
    Highly Efficacious Novel Vaccine, Humoral Immunity, and Ocular Herpes Simplex Virus 1: Reality or Myth?
    J Virol. 2017;91.
    PubMed    


    November 2017
  277. ERASMUS JH, Seymour RL, Kaelber JT, Kim DY, et al
    Novel insect-specific Eilat virus-based chimeric vaccine candidates provide durable, mono- and multi-valent, single dose protection against lethal alphavirus challenge.
    J Virol. 2017 Nov 29. pii: JVI.01274-17. doi: 10.1128/JVI.01274.
    PubMed     Abstract available


  278. MATASSOV D, Mire CE, Latham T, Geisbert JB, et al
    Single Dose Trivalent Vesiculovax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
    J Virol. 2017 Nov 15. pii: JVI.01190-17. doi: 10.1128/JVI.01190.
    PubMed     Abstract available


  279. JERE KC, Chaguza C, Bar-Zeev N, Lowe J, et al
    Emergence of double- and triple-gene reassortant G1P[8] rotaviruses possessing a DS-1-like backbone post rotavirus vaccine introduction in Malawi.
    J Virol. 2017 Nov 15. pii: JVI.01246-17. doi: 10.1128/JVI.01246.
    PubMed     Abstract available


  280. MALHERBE DC, Mendy J, Vang L, Barnette PT, et al
    Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C SHIV Mucosal Challenge.
    J Virol. 2017 Nov 1. pii: JVI.01092-17. doi: 10.1128/JVI.01092.
    PubMed     Abstract available


  281. GRESETH MD, Czarnecki MW, Bluma MS, Traktman P, et al
    Isolation and Characterization of vDeltaI3 Confirms that the Vaccinia Virus SSB Plays an Essential Role in Viral Replication.
    J Virol. 2017 Nov 1. pii: JVI.01719-17. doi: 10.1128/JVI.01719.
    PubMed     Abstract available


  282. VAN ERP EA, van Kasteren PB, Guichelaar T, Ahout IML, et al
    In Vitro Enhancement of Respiratory Syncytial Virus Infection by Maternal Antibodies Does Not Explain Disease Severity in Infants.
    J Virol. 2017;91.
    PubMed     Abstract available


  283. MONTEAGUDO PL, Lacasta A, Lopez E, Bosch L, et al
    BA71DeltaCD2: a New Recombinant Live Attenuated African Swine Fever Virus with Cross-Protective Capabilities.
    J Virol. 2017;91.
    PubMed     Abstract available


  284. WARING BM, Sjaastad LE, Fiege JK, Fay EJ, et al
    microRNA-based attenuation of influenza virus across susceptible hosts.
    J Virol. 2017 Nov 1. pii: JVI.01741-17. doi: 10.1128/JVI.01741.
    PubMed     Abstract available


    October 2017
  285. WANG X, Ku Z, Zhang X, Ye X, et al
    Structure, Immunogenicity and Protective Mechanism of an Engineered Enterovirus 71-Like Particle Vaccine Mimicking 80S Empty Capsid.
    J Virol. 2017 Oct 25. pii: JVI.01330-17. doi: 10.1128/JVI.01330.
    PubMed     Abstract available


  286. BOGDANOFF WA, Perez EI, Lopez T, Arias CF, et al
    Structural basis for the escape of human astrovirus from antibody neutralization: broad implications for rational vaccine design.
    J Virol. 2017 Oct 25. pii: JVI.01546-17. doi: 10.1128/JVI.01546.
    PubMed     Abstract available


  287. YORK J, Nunberg JH
    Epistastic interactions within the Junin virus envelope glycoprotein complex provide an evolutionary barrier to reversion in the live-attenuated Candid#1 vaccine.
    J Virol. 2017 Oct 25. pii: JVI.01682-17. doi: 10.1128/JVI.01682.
    PubMed     Abstract available


  288. SCHONE D, Hrycak CP, Windmann S, Lapuente D, et al
    Immunodominance of Adenovirus-Derived CD8+ T Cell Epitopes Interferes with the Induction of Transgene-Specific Immunity in Adenovirus-Based Immunization.
    J Virol. 2017;91.
    PubMed     Abstract available


  289. MURA M, Combredet C, Najburg V, Sanchez David RY, et al
    Nonencapsidated 5' Copy-Back Defective Interfering Genomes Produced by Recombinant Measles Viruses Are Recognized by RIG-I and LGP2 but Not MDA5.
    J Virol. 2017;91.
    PubMed     Abstract available


  290. MCGUIRE EP, Fong Y, Toote C, Cunningham CK, et al
    HIV exposed infants vaccinated with a MF59/rgp120 vaccine have higher magnitude anti-V1V2 IgG responses than adults immunized with the same vaccine.
    J Virol. 2017 Oct 11. pii: JVI.01070-17. doi: 10.1128/JVI.01070.
    PubMed     Abstract available


  291. SHEN X, Basu R, Sawant S, Beaumont D, et al
    HIV-1 gp120 Protein and MVAgp140 Boost Immunogens Increase immunogenicity of a DNA/MVA HIV-1 Vaccine.
    J Virol. 2017 Oct 11. pii: JVI.01077-17. doi: 10.1128/JVI.01077.
    PubMed     Abstract available


  292. WONG TM, Allen JD, Bebin-Blackwell AG, Carter DM, et al
    COBRA HA elicits hemagglutination-inhibition antibodies against a panel of H3N2 influenza virus co-circulating variants.
    J Virol. 2017 Oct 4. pii: JVI.01581-17. doi: 10.1128/JVI.01581.
    PubMed     Abstract available


  293. CARTER DM, Darby CA, Johnson SK, Carlock MA, et al
    Elicitation of protective antibodies against a broad panel of H1N1 viruses in ferrets pre-immune to historical H1N1 influenza viruses.
    J Virol. 2017 Oct 4. pii: JVI.01283-17. doi: 10.1128/JVI.01283.
    PubMed     Abstract available


  294. GOFF PH, Hayashi T, He W, Yao S, et al
    Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
    J Virol. 2017;91.
    PubMed     Abstract available


    September 2017
  295. URAKAMI A, Ngwe Tun MM, Moi ML, Sakurai A, et al
    Envelope-modified tetravalent dengue virus-like particle vaccine: implication for flavivirus vaccine design.
    J Virol. 2017 Sep 27. pii: JVI.01181-17. doi: 10.1128/JVI.01181.
    PubMed     Abstract available


  296. BAGRI P, Anipindi VC, Nguyen PV, Vitali D, et al
    A novel role for IL-17 in enhancing type 1 helper T cell immunity in the female genital tract following mucosal HSV-2 vaccination.
    J Virol. 2017 Sep 27. pii: JVI.01234-17. doi: 10.1128/JVI.01234.
    PubMed     Abstract available


  297. MOONEY AJ, Gabbard JD, Li Z, Dlugolenski DA, et al
    Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    J Virol. 2017 Sep 20. pii: JVI.01579-17. doi: 10.1128/JVI.01579.
    PubMed     Abstract available


  298. ANDERSEN TK, Zhou F, Cox R, Bogen B, et al
    A DNA vaccine that targets hemagglutinin to antigen presenting cells protects mice against H7 influenza.
    J Virol. 2017 Sep 20. pii: JVI.01340-17. doi: 10.1128/JVI.01340.
    PubMed     Abstract available


  299. RYERSON MR, Richards MM, Kvansakul M, Hawkins CJ, et al
    Vaccinia virus encodes a novel inhibitor of apoptosis that associates with the apoptosome.
    J Virol. 2017 Sep 13. pii: JVI.01385-17. doi: 10.1128/JVI.01385.
    PubMed     Abstract available


  300. SAUERMANN U, Radaelli A, Stolte-Leeb N, Raue K, et al
    Vector order determines protection against pathogenic simian immunodeficiency virus infection in a triple component vaccine by balancing CD4+ and CD8+ T-cell responses.
    J Virol. 2017 Sep 13. pii: JVI.01120-17. doi: 10.1128/JVI.01120.
    PubMed     Abstract available


  301. SULLIVAN JT, Sulli C, Nilo A, Yasmeen A, et al
    High-throughput Protein Engineering Improves the Antigenicity and Stability of Soluble HIV-1 Envelope Glycoprotein SOSIP Trimers.
    J Virol. 2017 Sep 6. pii: JVI.00862-17. doi: 10.1128/JVI.00862.
    PubMed     Abstract available


    August 2017
  302. BROOKE CB
    Population diversity and collective interactions during influenza virus replication and evolution.
    J Virol. 2017 Aug 30. pii: JVI.01164-17. doi: 10.1128/JVI.01164.
    PubMed     Abstract available


  303. LIU X, Liang B, Ngwuta J, Liu X, et al
    Attenuated human parainfluenza virus type 1 (HPIV1) expressing the respiratory syncytial virus (RSV) fusion F glycoprotein from an added gene: effects of pre-fusion stabilization and packaging of RSV F.
    J Virol. 2017 Aug 23. pii: JVI.01101-17. doi: 10.1128/JVI.01101.
    PubMed     Abstract available


    July 2017
  304. PHAN SI, Zengel JR, Wei H, Li Z, et al
    Parainfluenza virus 5 (PIV5) expressing wild-type or pre-fusion respiratory syncytial virus (RSV) fusion protein protect mice and cotton rats from RSV challenge.
    J Virol. 2017 Jul 26. pii: JVI.00560-17. doi: 10.1128/JVI.00560.
    PubMed     Abstract available


    May 2017
  305. SHEN X, Bogers WM, Yates NL, Ferrari G, et al
    Crosslinking of a CD4 Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques.
    J Virol. 2017 May 10. pii: JVI.00401-17. doi: 10.1128/JVI.00401.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: